Eli Lilly, Medtronic to collaborate on Parkinson's treatment

Seeking a new way to treat Parkinson's, Eli Lilly and Medtronic have agreed to work together on an approach that involves delivering a potential new medicine to the brain using an implantable drug delivery system. "By collaborating with Medtronic from the earliest phase of research, we are maximizing the potential for this therapy's efficient and effective development," said Michael Hutton, CSO of the neurodegeneration team at Lilly. News

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.